About: High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 February 1995

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в лютому 1995 (uk) article scientifique publié en 1995 (fr) im Februar 1995 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en febreru de 1995 (ast) artikull shkencor i botuar më 01 shkurt 1995 (sq) scientific article published on 01 February 1995 (en)
publication date	wds:Q72516724-6D382C4B-8CF4-4082-B824-9EE1E4AF8807
publication date	1995-02-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q72516724-576F1F7B-FB18-4CD5-AFC6-E9E83BF74801
language of work or name	English
author name string	wds:Q72516724-203DD41E-C241-4A6C-9C6E-FFF915404578 wds:Q72516724-43BCAB04-3921-4F55-B730-4EC224165BAC wds:Q72516724-699DDBBC-EF1E-4C01-9A6C-DBC5286D351C wds:Q72516724-8AFB1D43-313D-4D15-9716-AB3510343D5C wds:Q72516724-9F61311C-24AB-4D41-AD44-272670043F8D wds:Q72516724-A8C4FCBC-74F6-4F88-8D6A-F7F8AB940D58 wds:Q72516724-B106B5B9-BAD8-4A83-9B59-E7B8F3BC9F14 wds:Q72516724-C2015092-A003-4B0E-A358-77445B3AD2E8 wds:Q72516724-C7BA779B-60D2-4A0C-AD53-D52F70D1B9B1 wds:Q72516724-DFE23D8F-206B-4831-A0AC-EE3BD5307A35
author name string	B Gusterson A Jones J Prendiville N Sacks S Johnston I E Smith G Walsh H Robertshaw S Ebbs F Ramage
rdfs:label	High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer (en) High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer (nl) High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer (sq)
skos:prefLabel	High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer (en) High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer (nl) High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer (sq)
name	High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer (en) High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer (nl) High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer (sq)
title	wds:Q72516724-6E840463-2192-4B20-984F-7760356AF864
title	High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer (en)
page(s)	wds:Q72516724-0014CF3B-BF23-4BD4-AD84-771DC2D0306A
page(s)	424-429
instance of	wds:Q72516724-D6B7D07F-9691-41F0-926B-7E188C394C36
instance of	scholarly article
main subject	wds:Q72516724-2EAD8025-1273-4A4F-803D-4F8678001FE8 wds:Q72516724-9EC2A084-A9B5-434D-86CC-B9ACB7B7E4EA
main subject	breast cancer chemotherapy
PubMed ID	wds:Q72516724-4AA47948-4C1B-46E0-8364-FF6B47823308
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7844604
PubMed ID	7844604
published in	wds:Q72516724-C6D814A3-8CF6-4CA9-AF76-164B1F04112F
published in	Journal of Clinical Oncology
issue	wds:Q72516724-835E6359-B782-484C-8102-D48F6E6DAEB0
volume	wds:Q72516724-C4CA60C7-F7FE-4DAD-BF89-50A78D909F1D
issue	2
volume	13
DOI	wds:Q72516724-A859096B-1274-4000-AA40-8416EA5C7A99
DOI	http://dx.doi.org/10.1200/JCO.1995.13.2.424
DOI	10.1200/JCO.1995.13.2.424
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72516724
is cites work of	Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26-28, 2003, Philadelphia, Pennsylvania Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): Is prophylaxis required? Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapy Prognostic value of residual node involvement in operable breast cancer after induction chemotherapy Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer Platinum-based chemotherapy in metastatic breast cancer: current status. Reduced apoptosis and proliferation and increased Bcl-2 in residual breast cancer following preoperative chemotherapy Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS) Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi. Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: efficacy and safety in a prospective, randomized, phase II study Psychological factors can predict the response to primary chemotherapy in patients with locally advanced breast cancer Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study Preoperative/neoadjuvant medical therapy for early breast cancer Phase II study of neoadjuvant paclitaxel and cisplatin for operable and locally advanced breast cancer: analysis of 126 patients Is there still a role for neoadjuvant therapy in breast cancer? Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer Early changes in apoptosis and proliferation following primary chemotherapy for breast cancer Preoperative chemotherapy induces apoptosis in early breast cancer Neoadjuvant therapy for locally advanced breast cancer: Focus on chemotherapy and biological targeted treatments' armamentarium High complete pathological response in locally advanced breast cancer using paclitaxel and cisplatin Pre-operative chemotherapy and radiotherapy in breast cancer An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer Phase II study of continuous infusional 5-fluorouracil with epirubicin and carboplatin (instead of cisplatin) in patients with metastatic/locally advanced breast cancer (infusional ECarboF): a very active and well-tolerated outpatient regimen Combination chemotherapy with navelbine and continuous infusion of 5-fluorouracil in metastatic, chemotherapy refractory breast cancer Prediction of response to primary chemotherapy for operable breast cancer Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients: a phase II study Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer. the role of clinical response Epirubicin. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of breast cancer Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer: a phase II study Screening for breast cancer, time to think--and stop? The role of nuclear medicine in breast cancer detection: functional breast imaging Treatment of large and locally advanced breast cancers using neoadjuvant chemotherapy Clinical and pathological response to primary chemotherapy in operable breast cancer Primary chemotherapy in operable breast cancer with favorable prognostic factors: a pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software